tetradecanoylphorbol acetate and myricitrin

tetradecanoylphorbol acetate has been researched along with myricitrin in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, YC; Ko, CH; Lee, TJ; Shen, SC	1

Other Studies

1 other study(ies) available for tetradecanoylphorbol acetate and myricitrin

Article	Year
Myricetin inhibits matrix metalloproteinase 2 protein expression and enzyme activity in colorectal carcinoma cells. Molecular cancer therapeutics, 2005, Volume: 4, Issue:2 Topics: Antineoplastic Agents; Carcinoma; Cell Line, Tumor; Colorectal Neoplasms; Enzyme Activation; Flavonoids; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinase Inhibitors; Phosphorylation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Tetradecanoylphorbol Acetate	2005

Article

Year

Myricetin inhibits matrix metalloproteinase 2 protein expression and enzyme activity in colorectal carcinoma cells.

Molecular cancer therapeutics, 2005, Volume: 4, Issue:2

Topics: Antineoplastic Agents; Carcinoma; Cell Line, Tumor; Colorectal Neoplasms; Enzyme Activation; Flavonoids; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinase Inhibitors; Phosphorylation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Tetradecanoylphorbol Acetate

2005